Literature DB >> 19624567

Contribution of naïve and memory T-cell populations to the human alloimmune response.

C Macedo1, E A Orkis, I Popescu, B D Elinoff, A Zeevi, R Shapiro, F G Lakkis, D Metes.   

Abstract

T-cell alloimmunity plays a dominant role in allograft rejection. The precise contribution of naïve and memory T cells to this response however remains unclear. To address this question, we established an ex vivo flow-cytometric assay that simultaneously measures proliferation, precursor frequency and effector molecule (IFNgamma, granzyme B/perforin) production of alloreactive T cells. By applying this assay to peripheral blood mononuclear cells from healthy volunteers, we demonstrate that the CD4+ and CD8+ populations mount similar proliferative responses and contain comparable frequencies of alloreactive precursors. Effector molecule expression, however, was significantly higher among CD8+ T cells. Analysis of sorted naïve and memory T cells showed that alloreactive precursors were equally present in both populations. The CD8+ effector and terminally differentiated effector memory subsets contained the highest proportion of granzyme B/perforin after allostimulation, suggesting that these cells present a significant threat to transplanted organs. Finally, we demonstrate that virus-specific lymphocytes contribute significantly to the alloresponse in certain responder-stimulator HLA combinations, underscoring the importance of T-cell cross-reactivity in alloimmunity. These results provide a quantitative assessment of the roles of naïve and memory T-cell subsets in the normal human alloimmune response and establish a platform for measuring T-cell alloreactivity pre- and posttransplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624567     DOI: 10.1111/j.1600-6143.2009.02742.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  71 in total

1.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

2.  Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.

Authors:  Martin H Oberbarnscheidt; Jeffrey M Walch; Qi Li; Amanda L Williams; John T Walters; Rosemary A Hoffman; Anthony J Demetris; Craig Gerard; Geoffrey Camirand; Fadi G Lakkis
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

Review 3.  Detecting adaptive immunity: applications in transplantation monitoring.

Authors:  Georg A Böhmig; Markus Wahrmann; Marcus D Säemann
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

Review 4.  A brief journey through the immune system.

Authors:  Karim M Yatim; Fadi G Lakkis
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-06       Impact factor: 8.237

Review 5.  The innate immune system in transplantation.

Authors:  Martin H Oberbarnscheidt; Daniel Zecher; Fadi G Lakkis
Journal:  Semin Immunol       Date:  2011-07-01       Impact factor: 11.130

6.  Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Authors:  Jeffrey M Walch; Qiang Zeng; Qi Li; Martin H Oberbarnscheidt; Rosemary A Hoffman; Amanda L Williams; David M Rothstein; Warren D Shlomchik; Jiyun V Kim; Geoffrey Camirand; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

Review 7.  Memory T cells in organ transplantation: progress and challenges.

Authors:  Jaclyn R Espinosa; Kannan P Samy; Allan D Kirk
Journal:  Nat Rev Nephrol       Date:  2016-02-29       Impact factor: 28.314

Review 8.  The impact of infection and tissue damage in solid-organ transplantation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

Review 9.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

10.  Allograft outcomes in outbred mice.

Authors:  D K Reichenbach; Q Li; R A Hoffman; A L Williams; W D Shlomchik; D M Rothstein; A J Demetris; F G Lakkis
Journal:  Am J Transplant       Date:  2013-01-11       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.